Activation of the endocannabinoid system in schizophrenia: A compensatory mechanism of subclinical inflammation?
Schizophr Res
.
2023 Feb:252:67-68.
doi: 10.1016/j.schres.2022.12.050.
Epub 2023 Jan 9.
Authors
Błażej Misiak
1
,
Tomasz Bielawski
1
,
Jerzy Samochowiec
2
,
Agnieszka Samochowiec
3
,
Mariusz G Fleszar
4
,
Paulina Fortuna
4
,
Bogna Kosyk
5
,
Dorota Frydecka
6
Affiliations
1
Department of Psychiatry, Wroclaw Medical University, Wroclaw, Poland.
2
Department of Psychiatry, Pomeranian Medical University, Szczecin, Poland.
3
Department of Clinical Psychology, Institute of Psychology, University of Szczecin, Poland.
4
Department of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
5
Institute of Soil Science and Environmental Protection, Wroclaw, Poland; University of Environmental and Life Sciences, Wroclaw, Poland.
6
Department of Psychiatry, Wroclaw Medical University, Wroclaw, Poland. Electronic address: dfrydecka@gmail.com.
PMID:
36628871
DOI:
10.1016/j.schres.2022.12.050
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Endocannabinoids*
Humans
Inflammation
Receptor, Cannabinoid, CB1
Schizophrenia*
Substances
Endocannabinoids
Receptor, Cannabinoid, CB1